{"entity":{"type":"insider","cik":"0001817199","url":"/insider/0001817199","json_url":"/insider/0001817199.json","name":"Ring Christine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":76,"n_filings":60,"first":"2021-02-22","last":"2026-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Ring Christine","source":"filing","n_filings":60,"first_seen":"2021-02-22","last_seen":"2026-08-03"}],"transactions":[{"id":5937854,"accession":"0001817199-26-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001817199-26-000028","line_url":"/filing/0001817199-26-000028#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16589.0,"shares_display":"16,589","price_per_share":23.0489,"price_display":"23.05","price_state":"stated","total_value":382358.2021,"total_display":"382,358.20","total_whole":"382,358","shares_owned_after":9110.0,"shares_owned_after_display":"9,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-03","scope":"insider"},{"id":5970165,"accession":"0001817199-26-000026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001817199-26-000026","line_url":"/filing/0001817199-26-000026#line-4","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3847.0,"shares_display":"3,847","price_per_share":23.3828,"price_display":"23.38","price_state":"stated","total_value":89953.6316,"total_display":"89,953.63","total_whole":"89,954","shares_owned_after":19912.0,"shares_owned_after_display":"19,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-30","filed_date":"2026-07-30","scope":"insider"},{"id":5818739,"accession":"0001817199-26-000024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001817199-26-000024","line_url":"/filing/0001817199-26-000024#line-3","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11008.0,"shares_display":"11,008","price_per_share":23.5616,"price_display":"23.56","price_state":"stated","total_value":259366.0928,"total_display":"259,366.09","total_whole":"259,366","shares_owned_after":13579.0,"shares_owned_after_display":"13,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-02","scope":"insider"},{"id":5753214,"accession":"0001817199-26-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001817199-26-000022","line_url":"/filing/0001817199-26-000022#line-3","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28935.0,"shares_display":"28,935","price_per_share":20.0624,"price_display":"20.06","price_state":"stated","total_value":580505.544,"total_display":"580,505.54","total_whole":"580,506","shares_owned_after":13579.0,"shares_owned_after_display":"13,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-25","scope":"insider"},{"id":5950148,"accession":"0001817199-26-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001817199-26-000020","line_url":"/filing/0001817199-26-000020#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8148.0,"shares_display":"8,148","price_per_share":16.5995,"price_display":"16.60","price_state":"stated","total_value":135252.726,"total_display":"135,252.73","total_whole":"135,253","shares_owned_after":13579.0,"shares_owned_after_display":"13,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-02","scope":"insider"},{"id":5771385,"accession":"0001817199-26-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001817199-26-000018","line_url":"/filing/0001817199-26-000018#line-1","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8148.0,"shares_display":"8,148","price_per_share":16.9624,"price_display":"16.96","price_state":"stated","total_value":138209.6352,"total_display":"138,209.64","total_whole":"138,210","shares_owned_after":18305.0,"shares_owned_after_display":"18,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-04","scope":"insider"},{"id":5829423,"accession":"0001817199-26-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001817199-26-000016","line_url":"/filing/0001817199-26-000016#line-1","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5394.0,"shares_display":"5,394","price_per_share":16.7606,"price_display":"16.76","price_state":"stated","total_value":90406.6764,"total_display":"90,406.68","total_whole":"90,407","shares_owned_after":26453.0,"shares_owned_after_display":"26,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider"},{"id":6100107,"accession":"0001817199-26-000014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001817199-26-000014","line_url":"/filing/0001817199-26-000014#line-4","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3214.0,"shares_display":"3,214","price_per_share":16.6453,"price_display":"16.65","price_state":"stated","total_value":53497.9942,"total_display":"53,497.99","total_whole":"53,498","shares_owned_after":31847.0,"shares_owned_after_display":"31,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-04-30","scope":"insider"},{"id":6141628,"accession":"0001817199-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001817199-26-000012","line_url":"/filing/0001817199-26-000012#line-1","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8148.0,"shares_display":"8,148","price_per_share":15.2367,"price_display":"15.24","price_state":"stated","total_value":124148.6316,"total_display":"124,148.63","total_whole":"124,149","shares_owned_after":26453.0,"shares_owned_after_display":"26,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-02","scope":"insider"},{"id":5950141,"accession":"0001817199-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001817199-26-000010","line_url":"/filing/0001817199-26-000010#line-1","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8148.0,"shares_display":"8,148","price_per_share":15.4385,"price_display":"15.44","price_state":"stated","total_value":125792.898,"total_display":"125,792.90","total_whole":"125,793","shares_owned_after":34601.0,"shares_owned_after_display":"34,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-02","scope":"insider"},{"id":5806118,"accession":"0001817199-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001817199-26-000006","line_url":"/filing/0001817199-26-000006#line-1","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14261.0,"shares_display":"14,261","price_per_share":16.6621,"price_display":"16.66","price_state":"stated","total_value":237618.2081,"total_display":"237,618.21","total_whole":"237,618","shares_owned_after":42749.0,"shares_owned_after_display":"42,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-09","scope":"insider"},{"id":5852125,"accession":"0001817199-26-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001817199-26-000004","line_url":"/filing/0001817199-26-000004","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4421.0,"shares_display":"4,421","price_per_share":16.598307034607554,"price_display":"16.60","price_state":"stated","total_value":73381.1154,"total_display":"73,381.12","total_whole":"73,381","shares_owned_after":57098.0,"shares_owned_after_display":"57,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-01-30","scope":"insider","n_lines":2},{"id":6082087,"accession":"0001817199-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001817199-26-000002","line_url":"/filing/0001817199-26-000002#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3760.0,"shares_display":"3,760","price_per_share":18.4237,"price_display":"18.42","price_state":"stated","total_value":69273.112,"total_display":"69,273.11","total_whole":"69,273","shares_owned_after":50897.0,"shares_owned_after_display":"50,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider"},{"id":4102987,"accession":"0001817199-25-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001817199-25-000010","line_url":"/filing/0001817199-25-000010","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3760.0,"shares_display":"3,760","price_per_share":17.902743617021276,"price_display":"17.90","price_state":"stated","total_value":67314.316,"total_display":"67,314.32","total_whole":"67,314","shares_owned_after":51097.0,"shares_owned_after_display":"51,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-18","scope":"insider","n_lines":2},{"id":4396182,"accession":"0001817199-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001817199-25-000007","line_url":"/filing/0001817199-25-000007#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37600.0,"shares_display":"37,600","price_per_share":17.0664,"price_display":"17.07","price_state":"stated","total_value":641696.64,"total_display":"641,696.64","total_whole":"641,697","shares_owned_after":50897.0,"shares_owned_after_display":"50,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-24","scope":"insider"},{"id":4643615,"accession":"0001817199-25-000005","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001817199-25-000005","line_url":"/filing/0001817199-25-000005#line-5","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3644.0,"shares_display":"3,644","price_per_share":12.7967,"price_display":"12.80","price_state":"stated","total_value":46631.1748,"total_display":"46,631.17","total_whole":"46,631","shares_owned_after":50897.0,"shares_owned_after_display":"50,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-30","filed_date":"2025-10-30","scope":"insider"},{"id":4219080,"accession":"0001549595-25-000100","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001549595-25-000100","line_url":"/filing/0001549595-25-000100#line-5","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3841.0,"shares_display":"3,841","price_per_share":12.011,"price_display":"12.01","price_state":"stated","total_value":46134.251,"total_display":"46,134.25","total_whole":"46,134","shares_owned_after":44009.0,"shares_owned_after_display":"44,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-30","filed_date":"2025-07-30","scope":"insider"},{"id":4179442,"accession":"0001549595-25-000060","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001549595-25-000060","line_url":"/filing/0001549595-25-000060#line-4","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2894.0,"shares_display":"2,894","price_per_share":11.5017,"price_display":"11.50","price_state":"stated","total_value":33285.9198,"total_display":"33,285.92","total_whole":"33,286","shares_owned_after":37318.0,"shares_owned_after_display":"37,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-30","filed_date":"2025-04-30","scope":"insider"},{"id":4691544,"accession":"0001549595-25-000026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001549595-25-000026","line_url":"/filing/0001549595-25-000026","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5760.0,"shares_display":"5,760","price_per_share":19.953796875,"price_display":"19.95","price_state":"stated","total_value":114933.87,"total_display":"114,933.87","total_whole":"114,934","shares_owned_after":32638.0,"shares_owned_after_display":"32,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-03","scope":"insider","n_lines":2},{"id":4081811,"accession":"0001549595-25-000024","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001549595-25-000024","line_url":"/filing/0001549595-25-000024","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3220.0,"shares_display":"3,220","price_per_share":19.853685341614906,"price_display":"19.85","price_state":"stated","total_value":63928.8668,"total_display":"63,928.87","total_whole":"63,929","shares_owned_after":32829.0,"shares_owned_after_display":"32,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-30","scope":"insider","n_lines":2},{"id":4720917,"accession":"0001549595-25-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-25-000002","line_url":"/filing/0001549595-25-000002#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5760.0,"shares_display":"5,760","price_per_share":19.4956,"price_display":"19.50","price_state":"stated","total_value":112294.656,"total_display":"112,294.66","total_whole":"112,295","shares_owned_after":28084.0,"shares_owned_after_display":"28,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-02","scope":"insider"},{"id":2912648,"accession":"0001549595-24-000158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000158","line_url":"/filing/0001549595-24-000158#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5760.0,"shares_display":"5,760","price_per_share":21.7283,"price_display":"21.73","price_state":"stated","total_value":125155.008,"total_display":"125,155.01","total_whole":"125,155","shares_owned_after":28084.0,"shares_owned_after_display":"28,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-02","scope":"insider"},{"id":2693709,"accession":"0001549595-24-000156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000156","line_url":"/filing/0001549595-24-000156#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3290.0,"shares_display":"3,290","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":82250.0,"total_display":"82,250.00","total_whole":"82,250","shares_owned_after":28084.0,"shares_owned_after_display":"28,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-04","scope":"insider"},{"id":2356913,"accession":"0001549595-24-000154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000154","line_url":"/filing/0001549595-24-000154#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5760.0,"shares_display":"5,760","price_per_share":24.2824,"price_display":"24.28","price_state":"stated","total_value":139866.624,"total_display":"139,866.62","total_whole":"139,867","shares_owned_after":28084.0,"shares_owned_after_display":"28,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-01","scope":"insider"},{"id":2559555,"accession":"0001549595-24-000146","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001549595-24-000146","line_url":"/filing/0001549595-24-000146#line-4","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4182.0,"shares_display":"4,182","price_per_share":24.305,"price_display":"24.30","price_state":"stated","total_value":101643.51,"total_display":"101,643.51","total_whole":"101,644","shares_owned_after":28084.0,"shares_owned_after_display":"28,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-30","filed_date":"2024-10-30","scope":"insider"},{"id":2160383,"accession":"0001549595-24-000133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000133","line_url":"/filing/0001549595-24-000133#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3290.0,"shares_display":"3,290","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":82250.0,"total_display":"82,250.00","total_whole":"82,250","shares_owned_after":24592.0,"shares_owned_after_display":"24,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-14","filed_date":"2024-10-15","scope":"insider"},{"id":3128507,"accession":"0001549595-24-000122","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001549595-24-000122","line_url":"/filing/0001549595-24-000122","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5760.0,"shares_display":"5,760","price_per_share":22.225230208333333,"price_display":"22.23","price_state":"stated","total_value":128017.326,"total_display":"128,017.33","total_whole":"128,017","shares_owned_after":24892.0,"shares_owned_after_display":"24,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-01","scope":"insider","n_lines":2},{"id":3082356,"accession":"0001549595-24-000116","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001549595-24-000116","line_url":"/filing/0001549595-24-000116","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9050.0,"shares_display":"9,050","price_per_share":24.94319502762431,"price_display":"24.94","price_state":"stated","total_value":225735.915,"total_display":"225,735.92","total_whole":"225,736","shares_owned_after":24792.0,"shares_owned_after_display":"24,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-03","scope":"insider","n_lines":2},{"id":2356908,"accession":"0001549595-24-000114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001549595-24-000114","line_url":"/filing/0001549595-24-000114#line-3","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9870.0,"shares_display":"9,870","price_per_share":25.0094,"price_display":"25.01","price_state":"stated","total_value":246842.778,"total_display":"246,842.78","total_whole":"246,843","shares_owned_after":24592.0,"shares_owned_after_display":"24,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider"},{"id":2401515,"accession":"0001549595-24-000109","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001549595-24-000109","line_url":"/filing/0001549595-24-000109","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5760.0,"shares_display":"5,760","price_per_share":21.433782291666667,"price_display":"21.43","price_state":"stated","total_value":123458.586,"total_display":"123,458.59","total_whole":"123,459","shares_owned_after":24892.0,"shares_owned_after_display":"24,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-01","scope":"insider","n_lines":2},{"id":2480592,"accession":"0001549595-24-000105","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001549595-24-000105","line_url":"/filing/0001549595-24-000105#line-4","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2920.0,"shares_display":"2,920","price_per_share":20.6677,"price_display":"20.67","price_state":"stated","total_value":60349.684,"total_display":"60,349.68","total_whole":"60,350","shares_owned_after":24592.0,"shares_owned_after_display":"24,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-07-30","scope":"insider"},{"id":2160357,"accession":"0001549595-24-000090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001549595-24-000090","line_url":"/filing/0001549595-24-000090","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5760.0,"shares_display":"5,760","price_per_share":20.8050153125,"price_display":"20.81","price_state":"stated","total_value":119836.8882,"total_display":"119,836.89","total_whole":"119,837","shares_owned_after":20639.0,"shares_owned_after_display":"20,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-01","scope":"insider","n_lines":2},{"id":2988497,"accession":"0001549595-24-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000081","line_url":"/filing/0001549595-24-000081#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1864.0,"shares_display":"1,864","price_per_share":17.0178,"price_display":"17.02","price_state":"stated","total_value":31721.1792,"total_display":"31,721.18","total_whole":"31,721","shares_owned_after":19838.0,"shares_owned_after_display":"19,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-13","scope":"insider"},{"id":2728108,"accession":"0001549595-24-000079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000079","line_url":"/filing/0001549595-24-000079#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":17.01,"price_display":"17.01","price_state":"stated","total_value":32319.0,"total_display":"32,319.00","total_whole":"32,319","shares_owned_after":19838.0,"shares_owned_after_display":"19,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-12","scope":"insider"},{"id":2356895,"accession":"0001549595-24-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000077","line_url":"/filing/0001549595-24-000077#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":17.0025,"price_display":"17.00","price_state":"stated","total_value":6801.0,"total_display":"6,801.00","total_whole":"6,801","shares_owned_after":19838.0,"shares_owned_after_display":"19,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-05","scope":"insider"},{"id":2426495,"accession":"0001549595-24-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001549595-24-000075","line_url":"/filing/0001549595-24-000075#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1596.0,"shares_display":"1,596","price_per_share":17.0131,"price_display":"17.01","price_state":"stated","total_value":27152.9076,"total_display":"27,152.91","total_whole":"27,153","shares_owned_after":19838.0,"shares_owned_after_display":"19,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-03","scope":"insider"},{"id":2046784,"accession":"0001549595-24-000053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001549595-24-000053","line_url":"/filing/0001549595-24-000053#line-3","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1513.0,"shares_display":"1,513","price_per_share":12.0422,"price_display":"12.04","price_state":"stated","total_value":18219.8486,"total_display":"18,219.85","total_whole":"18,220","shares_owned_after":19838.0,"shares_owned_after_display":"19,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-30","filed_date":"2024-04-30","scope":"insider"},{"id":2966098,"accession":"0001549595-24-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001549595-24-000007","line_url":"/filing/0001549595-24-000007#line-3","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1760.0,"shares_display":"1,760","price_per_share":7.9902,"price_display":"7.99","price_state":"stated","total_value":14062.752,"total_display":"14,062.75","total_whole":"14,063","shares_owned_after":17427.0,"shares_owned_after_display":"17,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-30","scope":"insider"},{"id":8448796,"accession":"0001549595-23-000059","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001549595-23-000059","line_url":"/filing/0001549595-23-000059#line-3","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1232.0,"shares_display":"1,232","price_per_share":5.1974,"price_display":"5.20","price_state":"stated","total_value":6403.1968,"total_display":"6,403.20","total_whole":"6,403","shares_owned_after":15263.0,"shares_owned_after_display":"15,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-31","filed_date":"2023-11-01","scope":"insider"},{"id":7898783,"accession":"0001209191-23-043979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-043979","line_url":"/filing/0001209191-23-043979#line-3","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1420.0,"shares_display":"1,420","price_per_share":9.6547,"price_display":"9.65","price_state":"stated","total_value":13709.674,"total_display":"13,709.67","total_whole":"13,710","shares_owned_after":12544.0,"shares_owned_after_display":"12,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-01","scope":"insider"},{"id":8495452,"accession":"0001209191-23-026519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-026519","line_url":"/filing/0001209191-23-026519#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682.0,"shares_display":"682","price_per_share":9.8763,"price_display":"9.88","price_state":"stated","total_value":6735.6366,"total_display":"6,735.64","total_whole":"6,736","shares_owned_after":10040.0,"shares_owned_after_display":"10,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-02","scope":"insider"},{"id":8701229,"accession":"0001209191-23-005906","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-005906","line_url":"/filing/0001209191-23-005906#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001817199","owner_name":"Ring Christine","owner_display_name":"Ring Christine","owner_url":"/insider/0001817199","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":848.0,"shares_display":"848","price_per_share":11.7796,"price_display":"11.78","price_state":"stated","total_value":9989.1008,"total_display":"9,989.10","total_whole":"9,989","shares_owned_after":7261.0,"shares_owned_after_display":"7,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"}],"collapsed":true,"next_cursor":"2023-01-30|8701229","ledger_fault":false,"count":{"value":76,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":76,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":76},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001549595","name":"Nurix Therapeutics, Inc.","url":"/issuer/0001549595","role":"Officer (Chief Legal Officer)","n_filings":60,"first_seen":"2021-02-22","last_seen":"2026-08-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001817199","retrieved_at":"2026-08-26T17:26:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}